HealthTech
India’s Cardiotrack secures $2M in Pre-series A funding led by seasoned angel investor
Cardiotrack, an India-based provider health-tech firm, has on Monday announced that it has received $2 million in Pre series-A funding. The funding is coming from a slew of investors, led by seasoned angel investor Girish Narasimhan, Managing Director and Principal, Corporate Finance Associates Worldwide Inc.
How AI will disrupt & spark innovations in healthcare? Let’s hear from Vertex Growth’s Nikodemus Jaya [Q&A]
In an interview with TNGlobal, Vertex Growth Executive Director Nikodemus Jaya has also discussed how AI will have an impact on the healthcare sector. He shared his insights on what are the areas AI would transform the healthcare sector the most, among other issues. He also shared his views on what kind of training healthcare workers would need to fully…
US’s Aptar Digital Health acquires Singapore healthcare firm Healint
Aptar Digital Health, a global digital health solutions provider, has on Wednesday announced that it has acquired Healint, a Singapore-based digital health company. The acquisition of Healint aligns with Aptar Digital Health strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment.
The power of a Village to raise mental well-being
As tech improves, it is essential to know its place and context for our #MentalHealth and #WellBeing - to support and enhance human connection, not replace it.
Doctor Anywhere enhances preventive health and wellness capabilities with integrated medical facility DA MedSuites
Singapore-based healthcare company Doctor Anywhere(DA) has announced the opening of its flagship health screening and imaging center, DA MedSuites. As the company's premier one-stop medical facility in Singapore, DA MedSuites represents the latest milestone in its mission to deliver quality, comprehensive healthcare in the region.
Australia’s Prota Therapeutics secures $21M in financing led by SPRIM Global Investments
Prota Therapeutics Pty Ltd (Prota), an Australian biotechnology company focused on the development of novel oral immunotherapy treatments that induce remission of allergy, has on Tuesday announced financing of $21 million in equity and debt financing. The round is led by Singapore-based SPRIM Global Investments (SGI).
Entrepreneurial evolution: Redefining business models at the forefront of pharmaceutical Innovation
As the #pharmaceutical industry continues to evolve, embracing community-centric approaches could be the key to addressing the pressing challenges of today's pharmaceutical landscape. #HealthTech #BigPharma
Corrective Aesthetics partners Teda Technology to tackle Malaysia’s rising mental health crisis
In response to the escalating mental health crisis in Malaysia, tech firms Corrective Aesthetics Sdn Bhd and Teda Technology Sdn Bhd have announced a groundbreaking collaboration to expand the Remind program, a mobile application that is designed to diagnose users' mental states through voice recordings.
Navigating the landscape of novel gene therapies: How small countries can unlock the global gene therapy market
The future of #biotech investments hinges on the continued evolution of gene therapies and the integration of novel technologies into biological research standards ... In this dynamic landscape, small countries such as #Singapore and #Estonia might achieve catalyzing potential by providing relevant, consistent, and innovation-driven regulatory frameworks to…
India’s PlasmaGen Biosciences completes $27M equity financing
PlasmaGen Biosciences, a biopharmaceutical company focused on blood plasma-derived pharmaceutical products for India and emerging markets, announced that it has raised 225 crores ($27 million) in equity financing. The funding was coming from United Kingdom based Artian Investments, prominent public market investor Ashish Kacholia, pharmaceutical…
